Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $10.67 Analyst target: $21.50 Upside: 101.50%
ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.
See the full interactive analysis & chart →Informational only — not investment advice.